Your session is about to expire
← Back to Search
Kisspeptin for Diabetes Control
Study Summary
This trial looks at how a protein called kisspeptin might help control blood sugar and insulin levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- My puberty development was normal.A close family member has diabetes.You have not gained or lost a significant amount of weight in the past three months.I am a postmenopausal woman without protein C resistance.None of my immediate family has diabetes.I have been diagnosed with low testosterone.I can stop my hormone therapy for a specified time if needed.I haven't taken any drugs recently that affect metabolism or reproduction, except for thyroid or allergy meds.It seems like there might be a typo in your request. Could you please provide more context or clarify the term "Inclusion/"?I have had a condition where my lymphocytes grow abnormally.Your body mass index (BMI) is not in the specified range.Your BUN and creatinine levels are not high.Your blood pressure is not too high (systolic < 140 mm Hg, diastolic < 90 mm Hg).You have been diagnosed with a condition where your body has trouble processing sugar after drinking a sugary solution.Your body mass index (BMI) is within the range of 18.5 to 25.My hemoglobin levels are normal, or slightly low if I have low sex hormone levels.I have no issues with having my blood drawn.Your hemoglobin A1C level is less than 6.5%.Women must have a negative pregnancy test.I haven't had any cancer, except for skin cancer, in the last 5 years.You have regular periods.Your liver enzyme levels are not more than three times the normal limit.I have a history of cancer.You do not have high levels of fats in your blood when fasting.I have no chronic diseases, except for my thyroid condition which is under control.
- Group 1: Kisspeptin and Insulin Resistance Test
- Group 2: Placebo and Insulin Resistance Test
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can kisspeptin 112-121 be utilized without risking harm to patients?
"Despite the lack of substantial efficacy and safety data, kisspeptin 112-121 has been assigned a score of 1. This indicates that it is in its earliest phase of clinical trial development."
What is the size of the participant pool for this medical experiment?
"Affirmative. Details on clinicaltrials.gov attest to the fact that this medical study, which was originally published June 6th 2017, is currently recruiting individuals. A total of 413 participants need to be enrolled from 1 trial centre."
What conditions must be satisfied for someone to join this research?
"In order to be considered for this clinical trial, potential participants must have impaired glucose tolerance and be between the ages of 18-60. A total of 413 individuals are being recruited that meet these criteria."
Are there any openings for partakers in this research?
"Affirmative. The clinicaltrials.gov database indicates that this investigation is actively seeking participants, having been posted on June 6th 2017 and recently updated on June 29th 2022. The project requires 413 patients to be recruited from one medical site."
Are there other research papers which have examined the effects of kisspeptin 112-121?
"At the present moment, there is 71 ongoing investigations into kisspeptin 112-121. Of those studies, 13 are in the advanced Phase 3 testing stage. Most of these experiments take place within Cincinnati, Ohio but they span 247 different sites around the globe."
Does this trial embrace geriatric populations?
"To be eligible to join this study, patients need to fall in the 18-60 age range. Conversely, there are 21 clinical trials for youth and 179 studies that cater towards seniors."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger